| 國立臺灣大學 |
2007-07 |
Long-term outcome and effects of oral bosentan therapy in Taiwanese patients with advanced idiopathic pulmonary arterial hypertension.
|
Hsu, Hsao-Hsun; Chen, Jin-Shing; Chen, Robert J.; Ko, Wen-Je; Kuo, Shuenn-Wen; Wu, En-Ting; Wu, Mei-Hwan; Wang, Jou-Kou; Lee, Yung-Chie |
| 國家衛生研究院 |
2010-06 |
Long-term outcome evaluation in young adults following clubfoot surgical release
|
Graf, A;Hassani, S;Krzak, J;Long, J;Caudill, A;Flanagan, A;Eastwood, D;Kuo, KN;Harris, G;Smith, P |
| 國立臺灣大學 |
2016 |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Li, Meng-Ju; Lee, Ni-Chung; Yang, Yung-Li; Yen, Hsiu-Ju; Chang, Hsiu-Hao; Chien, Yin-Hsiu; Lu, Meng-Yao; Jou, Shiann-Tarng; Lin, Kai-Hsin; Hwu, Wuh-Liang; Lin, Dong-Tsamn; 李孟儒; 林東燦; 胡務亮; 周獻堂; 李妮鍾; 簡穎秀; 盧孟佑; 張修豪; 林凱信; 楊永立 |
| 臺大學術典藏 |
2020-12-09T01:38:22Z |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Li M.-J.; NI-CHUNG LEE; Yang Y.-L.; Yen H.-J.; Chang H.-H.; Chien Y.-H.; Lu M.-Y.; Jou S.-T.; Lin K.-H.; Hwu W.-L.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-09T02:07:52Z |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
MENG-JU LI; Lee N.-C.; Yang Y.-L.; Yen H.-J.; Chang H.-H.; Chien Y.-H.; Lu M.-Y.; Jou S.-T.; Lin K.-H.; Hwu W.-L.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-16T07:21:51Z |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Li M.-J.; Lee N.-C.; Yang Y.-L.; Yen H.-J.; Chang H.-H.; Chien Y.-H.; MENG-YAO LU; Jou S.-T.; Lin K.-H.; Hwu W.-L.; Lin D.-T. |
| 臺大學術典藏 |
2020-12-18T05:28:40Z |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Lin D.-T.; Lee N.-C.; Yang Y.-L.; Yen H.-J.; HSIU-HAO CHANG; Chien Y.-H.; Lu M.-Y.; Jou S.-T.; Lin K.-H.; Hwu W.-L.; Li M.-J. |
| 臺大學術典藏 |
2016 |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Lin D.-T.; Hwu W.-L.; Lin K.-H.; Li M.-J.; Lee N.-C.; Yang Y.-L.; Yen H.-J.; Chang H.-H.; YIN-HSIU CHIEN; Lu M.-Y.; Jou S.-T. |
| 臺大學術典藏 |
2016 |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Chien Y.-H.; Chang H.-H.; Yen H.-J.; Yang Y.-L.; Lee N.-C.; Li M.-J.; Li M.-J.;Lee N.-C.;Yang Y.-L.;Yen H.-J.;Chang H.-H.;Chien Y.-H.;Lu M.-Y.;Shiann-Tang Jou;Lin K.-H.;Hwu W.-L.;Lin D.-T.; Lu M.-Y.; SHIANN-TANG JOU; Lin K.-H.; Hwu W.-L.; Lin D.-T. |
| 臺大學術典藏 |
2021-01-06T03:39:00Z |
Long-term outcome for Down syndrome patients with hematopoietic disorders
|
Li M.-J.; Lee N.-C.; YUNG-LI YANG; Yen H.-J.; Chang H.-H.; Chien Y.-H.; Lu M.-Y.; Jou S.-T.; Lin K.-H.; Hwu W.-L.; Lin D.-T. |
